Pacific Biosciences of California, Inc.

8-K Director or officer change Jul 9, 2026 8-K Director or officer change; Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change; Regulation FD disclosure Mar 6, 2026 8-K Director or officer change; Regulation FD disclosure Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Director or officer change Feb 3, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Feb 2, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Results of operations (earnings release); Exit or disposal costs Apr 9, 2025 8-K Director or officer change; Regulation FD disclosure Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Mar 13, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K/A Director or officer change Feb 7, 2025 8-K Director or officer change; Regulation FD disclosure Jan 30, 2025 8-K Results of operations (earnings release); Other events Jan 14, 2025 8-K Director or officer change Dec 13, 2024 8-K/A Director or officer change Dec 13, 2024 8-K Director or officer change Dec 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 22, 2024 8-K Director or officer change Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Director or officer change Nov 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K/A Exit or disposal costs Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024